Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$5.04B |
| 2 |
NVIDIA
NVDA
|
+$2.69B |
| 3 |
Broadcom
AVGO
|
+$2.06B |
| 4 |
Invesco QQQ Trust
QQQ
|
+$1.46B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.36B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$667M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$649M |
| 3 |
TSMC
TSM
|
+$483M |
| 4 |
iShares Core US Aggregate Bond ETF
AGG
|
+$473M |
| 5 |
Walmart Inc
WMT
|
+$464M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.3% |
| 2 | Financials | 9.61% |
| 3 | Consumer Discretionary | 7.75% |
| 4 | Healthcare | 6.29% |
| 5 | Communication Services | 5.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5676
PUT
Intellia Therapeutics
NTLA
$1.49B
| $152K | ﹤0.01% |
16,200
| – | – |
|
5677
Gaia
GAIA
$46.8M
| $151K | ﹤0.01% |
34,471
+5,849
| +20% | +$26.7K |
|
5678
Protalix BioTherapeutics
PLX
$191M
| $151K | ﹤0.01% |
102,178
-187,283
| -65% | -$383K |
|
5679
Mammoth Energy Services
TUSK
$128M
| $150K | ﹤0.01% |
53,601
-12,987
| -20% | -$33.2K |
|
5680
Greenwich LifeSciences
GLSI
$198M
| $150K | ﹤0.01% |
+16,498
| New | +$157K |
|
5681
KVH Industries
KVHI
$181M
| $149K | ﹤0.01% |
27,883
+619
| +2% | +$3.19K |
|
5682
J. Jill
JILL
$272M
| $148K | ﹤0.01% |
10,112
-22,742
| -69% | -$360K |
|
5683
Outlook Therapeutics
OTLK
$183M
| $148K | ﹤0.01% |
92,368
-11,156
| -11% | -$17.8K |
|
5684
Rezolute
RZLT
$454M
| $148K | ﹤0.01% |
33,104
-203,105
| -86% | -$754K |
|
5685
Stem
STEM
$48.4M
| $147K | ﹤0.01% |
23,629
+4,020
| +21% | +$36K |
|
5686
Southland Holdings
SLND
$30.2M
| $147K | ﹤0.01% |
35,118
+4,505
| +15% | +$15.9K |
|
5687
Lexeo Therapeutics
LXEO
$324M
| $146K | ﹤0.01% |
36,368
-42,740
| -54% | -$141K |
|
5688
Waldencast
WALD
$222M
| $145K | ﹤0.01% |
59,275
-88,353
| -60% | -$224K |
|
5689
SuperCom
SPCB
$67.3M
| $145K | ﹤0.01% |
+13,965
| New | +$113K |
|
5690
Smartbird Inc
BIRD
$19.5M
| $144K | ﹤0.01% |
+13,589
| New | +$95.1K |
|
5691
Sagimet Biosciences
SGMT
$439M
| $142K | ﹤0.01% |
18,621
-4,982
| -21% | -$21K |
|
5692
Torrid Holdings
CURV
$254M
| $142K | ﹤0.01% |
48,057
+1,704
| +4% | +$8.92K |
|
|
CLPR
5693
Clipper Realty
CLPR
$45.2M
| $142K | ﹤0.01% |
38,568
-58,459
| -60% | -$223K |
|
5694
Hagerty
HGTY
$1.17B
| $140K | ﹤0.01% |
13,814
-23,569
| -63% | -$220K |
|
5695
Strawberry Fields REIT
STRW
$191M
| $138K | ﹤0.01% |
13,134
-4,048
| -24% | -$43.1K |
|
|
KAZR
5696
Skyline Builders Group
KAZR
$49.6M
| $138K | ﹤0.01% |
+10,947
| New | +$128K |
|
|
BULL
5697
Webull Corp
BULL
$3.75B
| $138K | ﹤0.01% |
+11,532
| New | +$179K |
|
5698
Veritone
VERI
$101M
| $136K | ﹤0.01% |
107,661
+38,640
| +56% | +$70.1K |
|
5699
Achieve Life Sciences
ACHV
$659M
| $135K | ﹤0.01% |
59,915
-50,431
| -46% | -$144K |
|
5700
TechTarget
TTGT
$325M
| $135K | ﹤0.01% |
17,427
-40,389
| -70% | -$321K |
|
Similar funds
Goldman Sachs's Q2 2025 Portfolio in Review
As of Q2 2025, Goldman Sachs held 6,593 positions worth $736B, up 19% from $618B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Goldman Sachs deployed $48.5B of net new capital in Q2 2025, opening 562 new positions and adding to 2,527 existing holdings. Its largest new stake was Emera Inc: 5,401,728 shares worth $248M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was iShares iBoxx $ High Yield Corporate Bond ETF, an estimated $667M trimmed.
- Goldman Sachs's largest Q2 2025 buy was Emera Inc: 5,401,728 shares worth $248M.
- Goldman Sachs added most to Tesla in Q2 2025, an estimated $5.04B increase.
- Goldman Sachs's biggest Q2 2025 reduction was iShares iBoxx $ High Yield Corporate Bond ETF, cutting an estimated $667M.
- Goldman Sachs fully exited Discover Financial Services in Q2 2025, selling an estimated $296M.
- Goldman Sachs's ten largest holdings make up 21% of its $736B portfolio in Q2 2025.
- Goldman Sachs opened 562 new positions and closed 544 in Q2 2025.
- Goldman Sachs's portfolio value rose 19% quarter-over-quarter to $736B.
Based on Goldman Sachs's 13F filing for Q2 2025, filed 14 Aug 2025.